Moteur de recherche d’entreprises européennes

Financement de l’UE (9 994 359 €) : Une plateforme européenne d’imagerie du cancer liée aux données biologiques et de santé pour l’intelligence artificielle de nouvelle génération et la médecine de … Hor 03/06/2020 Programme de recherche et d'innovation de l'UE « Horizon »

Vue d’ensemble

Texte

Une plateforme européenne d’imagerie du cancer liée aux données biologiques et de santé pour l’intelligence artificielle de nouvelle génération et la médecine de précision en oncologie

The goal of EuCanImage is to build a highly secure, federated and large-scale European cancer imaging platform, with capabilities that will greatly enhance the potential of artificial intelligence (AI) in oncology. Firstly, the EuCanImage platform will be populated with a completely new data resource totaling over 25,000 single subjects, which will allow to investigate unmet clinical needs like never before, such as for the detection of small liver lesions and metastases of colorectal cancer, or for estimating molecular subtypes of breast tumours and pathological complete response. Secondly, the cancer imaging platform, built by leveraging the well-established Euro-Bioimaging infrastructure, will be cross-linked to biological and health repositories through the European Genome-phenome Archive, allowing to develop multi-scale AI solutions that integrate organ-level, molecular and other clinical predictors into dense patient-specific cancer fingerprints. To deliver this platform, the consortium will build upon several key European initiatives in data sharing for personalised medicine research, including EUCANCAn (cancer genomics and health data sharing), euCanSHare (cardiac imaging and omics data sharing) and EUCAN-Connect (federated data analytics). Furthermore, to foster international cooperation and leverage existing success stories, the consortium comprises the coordinators of The Cancer Imaging Archive (TCIA), the US cancer imaging repository funded by the National Cancer Institute. This will allow EuCanImage to leverage a unique 10-year long experience in cancer imaging storage, anonymisation, curation and management. Finally, a close collaboration between world renown clinical, radiomics, AI and legal experts within the consortium and beyond will establish well-needed guidelines for AI development and validation named FUTURE, for delivering Fair, Universal, Traceable, Usable, Robust and Explainable decision support systems for future cancer care.


Barcelona Supercomputing Center Centro Nacional de Supercomputacion 351 250 €
Biobanks AND Biomolecular Resources Research Infrastructure Consortium (Bbmri-Eric) 310 425 €
Collective Minds Radiology AB 401 250 €
Eibir Gemeinnutzige GmbH ZUR Forderung DER Erforschung DER Biomedizinischen Bildgebung 273 125 €
Erasmus Universitair Medisch Centrum Rotterdam 931 563 €
European Association for Cancer Research 164 658 €
European Society OF Oncologic Imaging - Esoi Europaische Gesellschaftfur Onkologische Bildebung 18 727,93 €
Fundacio Centre de Regulacio Genomica 476 500 €
Fundacio de Recerca Clinic Barcelona-Institut D Investigacions Biomediques August Pi i Sunyer 467 500 €
Gdanski Uniwersytet Medyczny 339 625 €
Hospital Clinic de Barcelona 0,00 €
Lietuvos Sveikatos Mokslu Universiteto Ligonine Kauno Klinikos 181 188 €
Lynkeus 679 500 €
Oncoradiomics 472 500 €
Siemens Healthcare GmbH 292 372 €
Siemens Healthineers AG 184 832 €
TMF - Technologie UND Methodenplattform FUR DIE Vernetzte Medizinische Forschung e. V. 0,00 €
Umea Universitet 526 250 €
Universidad del Pais Vasco/ Euskal Herriko Unibertsitatea 187 500 €
Universita Di Pisa 481 250 €
Universitat de Barcelona 1 639 991 €
Universiteit Maastricht 808 875 €
University of Arkansas 805 479 €

https://cordis.europa.eu/project/id/952103

Cette annonce se réfère à une date antérieure et ne reflète pas nécessairement l’état actuel.